Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
RIEMSER Pharma logo — Pioneering specialized pharmaceuticals in oncology, anti-inf...

RIEMSER Pharma

Pioneering specialized pharmaceuticals in oncology, anti-infectives, and dermatology to address critical unmet medical needs.

Founded 1990 Series Unknown Biotechnology, Health Care +1

General Information

Company Name RIEMSER Pharma
Founded Year 1990
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when RIEMSER Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About RIEMSER Pharma

RIEMSER Pharma GmbH, previously known as RIEMSER Arzneimittel AG, is an international specialty pharmaceutical company founded in 1990. The company is pioneering specialized pharmaceuticals in oncology, anti-infectives, and dermatology to address critical unmet medical needs. RIEMSER Pharma is situated in Greifswald and has a rich SME culture and history. The company's primary focus is on the distribution and life cycle management of pharmaceuticals in therapeutic niche areas that address high unmet medical needs. Their core expertise lies in the fields of oncology, anti-infectives, and dermatology. The last investment was a Venture Round investment on 22 January 2008, with the investor being TVM Capital. As a player in the Biotechnology, Health Care, and Pharmaceutical industries, RIEMSER Pharma continues to make strides in addressing critical medical needs through its specialized pharmaceuticals.

Taxonomy: pharmaceuticals, oncology, anti-infectives, dermatology, specialty pharmaceuticals, life cycle management, therapeutic niche areas, unmet medical needs, international, SME culture, Greifswald, RIEMSER Pharma GmbH, RIEMSER Arzneimittel AG, history

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
22 Jan 2008
Private Equity Round •••••• 1
Investor
01 Jan 2005

RIEMSER Pharma Alternatives & Competitors

RIEMSER Pharma vs
Xcel Pharmaceuticals
Xcel Pharmaceuticals

Focused Innovation for CNS Disorders

Debt Financing
51-200 employees
Health Care, Manufacturing
RIEMSER Pharma vs
Anka Biyoteknoloji Ltd.
Anka Biyoteknoloji Ltd. Turkey

A biotechnology company harnesses advanced biological processes to develop innovative solutions for...

1 employees
Biotechnology, Health Care
RIEMSER Pharma vs
Waymade PLC
Waymade PLC United Kingdom

Dedicated to Rare Diseases

129 employees
Health Care, Logistics

FAQ About RIEMSER Pharma

Pioneering specialized pharmaceuticals in oncology, anti-infectives, and dermatology to address critical unmet medical needs.
RIEMSER Pharma was founded in 1990.
RIEMSER Pharma operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
RIEMSER Pharma has completed 2 funding rounds. The latest funding stage is Series Unknown.
Top alternatives and competitors to RIEMSER Pharma include Xcel Pharmaceuticals, Anka Biyoteknoloji Ltd., Waymade PLC, Gute Medical LLc., Oy Verman Ab. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RIEMSER Pharma and Xcel Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors RIEMSER Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy